Investment strategy
Columbus Venture Partners’ investment strategy is focused on early-stage and high growth opportunities of biotechnology, medical technology, pharmaceuticals and healthcare industries.
We have analyzed in detail the Spanish biotechnology sector, and have contrasted the opportunities for private investors, other venture capital funds, and pharmaceutical and biotechnology companies. Our conclusion is there is a huge opportunity to develop ideas and to transfer out advance technology of Universities and Research Centers into market driven companies.
IMPROVED INVESTMENT STRATEGY LEVERAGES RETURN
High value with alternative and attractive risk/reward profiles, commercially and scientifically differentiated.
Lean structure, cost efficient, accessible shared resources, access to low-cost incubator.
Hands-on investments. Founder ROI in investments: leverages return. Board role in 100% of the investments in the portfolio.
Projects co-invested or partnered with global VC firms and Top pharmaceutical companies. Preferred access to novel technologies.
IMPROVED INVESTMENT STRATEGY LEVERAGES RETURN
High value with alternative and attractive risk/reward profiles, commercially and scientifically differentiated.
Lean structure, cost efficient, accessible shared resources, access to low-cost incubator.
Hands-on investments. Founder ROI in investments: leverages return. Board role in 100% of the investments in the portfolio.
Projects co-invested or partnered with global VC firms and Top pharmaceutical companies. Preferred access to novel technologies.
THE EFFICIENT FRONTIER: A DIVERSIFIED PORTFOLIO WITH OPTIMIZED RISK – RETURN. WELL KNOWN MODERN PORTOFOLIOS THEORY AT ITS BEST
BASIC SCIENCE
COLUMBUS VENTURE PARTNERS, S.G.E.I.C., S.A
SEARCH
● Search of deal flow in Research Centers and early stage assets from existing companies.
● Collaboration agreements with TLOs.
TECHNOLOGY VALIDATION
● Assestment market needs.
● IP Position.
● Commercial Viability.
● Resources needed, timelines and milestones.
INCUBATION
● Business Plan.
● Scientific/Tech validation.
● Management.
● Networking.
NEWCO
ACCELERATION
● Project Development.
● Team.
● International.
● SAB/BoD.
● Search of deal flow in Research Centers and early stage assets from existing companies.
● Collaboration agreements with TLOs.
● Assestment market needs.
● IP Position.
● Commercial Viability.
● Resources needed, timelines and milestones.
● Business Plan.
● Scientific/Tech validation.
● Management.
● Networking.
● Project Development.
● Team.
● International.
● SAB/BoD.